CORD-19:c654596857bce9cdd64ffc51842048643107348c / 163969-164183 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1374","span":{"begin":0,"end":214},"obj":"Sentence"},{"id":"T72086","span":{"begin":0,"end":214},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The in vitro activities of the ketolides ABT-773 (A) and telithromycin (T) were compared to azithromycin (AZ) against clinical isolates of SP, Moraxella catarrhalis (M.cat), Haemophilis influenzae (H.flu) and MRSA."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T121","span":{"begin":0,"end":214},"obj":"Sentence"}],"text":"The in vitro activities of the ketolides ABT-773 (A) and telithromycin (T) were compared to azithromycin (AZ) against clinical isolates of SP, Moraxella catarrhalis (M.cat), Haemophilis influenzae (H.flu) and MRSA."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T696","span":{"begin":139,"end":141},"obj":"Disease"},{"id":"T697","span":{"begin":186,"end":196},"obj":"Disease"},{"id":"T698","span":{"begin":209,"end":213},"obj":"Disease"},{"id":"T646","span":{"begin":139,"end":141},"obj":"Disease"},{"id":"T20821","span":{"begin":186,"end":196},"obj":"Disease"},{"id":"T648","span":{"begin":209,"end":213},"obj":"Disease"}],"attributes":[{"id":"A696","pred":"mondo_id","subj":"T696","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A697","pred":"mondo_id","subj":"T697","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A698","pred":"mondo_id","subj":"T698","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A29393","pred":"mondo_id","subj":"T646","obj":"http://purl.obolibrary.org/obo/MONDO_0005972"},{"id":"A22513","pred":"mondo_id","subj":"T20821","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A15529","pred":"mondo_id","subj":"T648","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"}],"text":"The in vitro activities of the ketolides ABT-773 (A) and telithromycin (T) were compared to azithromycin (AZ) against clinical isolates of SP, Moraxella catarrhalis (M.cat), Haemophilis influenzae (H.flu) and MRSA."}